I already supplied data from numerous independent studies that examine that exact question.
Are you saying you haven't actually read any of them?
Want more? Okay, fine, here's just one jurisdiction which provides a wealth of data and a variety of breakdowns, including percentage of hospitalizations by vaccination status (this is a jurisdiction where >60% of eligible people are fully vaccinated and >75% are partially vaccinated, so there's a wealth of data about vaccine effectiveness):
> 92.1% of hospitalized cases (5,260/5,709) since Jan 1, 2021 were unvaccinated or diagnosed within two weeks from the first dose immunization date
I'll grant you that breakdown doesn't specifically break out Delta cases from non-VOC cases, but they also include a specific analysis of vaccine effectiveness versus Delta based on current data in the province:
> B.1.617 Variant [Partial] 57% (51 to 63%) [Complete] 85% (78 to 89%)
Now, this is a blended set of numbers across all vaccine types, and so represents the average effectiveness across Pfizer, Moderna, and AZ. So there's some nuance that's missing, here.
Regardless, even with just a single dose of a COVID vaccine the average effectiveness versus Delta of symptomatic illness is greater than 50%, which, as I previously noted, will absolutely put a significant dent in the R-value. And 85% is absolutely fantastic.
Alright, I showed you mine, now you show me yours.
Real data from a reputable source would be more than sufficient.
Remarkable how you seem to be unable to produce any...